GT Biopharma Inc. Common Stock

$0.4690

+0.0111 (+2.42%)

Volume:

501.447K ($230.80K)

#2506 Volume #4260 Dollar Volume

Market Capitalization:

$4.99M

#5209 Market Cap

GT Biopharma Price Chart

GT Biopharma Volume Chart

GT Biopharma Market Segments

After Hours

+0.0001(+0.02%)

Open	$0.4689
Close	$0.4690
Low	$0.4500
Low Change	-0.0189 (-4.03%)
High	$0.4690
High Change	+0.0001 (+0.02%)
Range	$0.0190
Volume	10.607K
Dollar Volume	$4.97K

Regular Trading Hours

+0.0154(+3.46%)

Open	$0.4450
Close	$0.4604
Low	$0.4332
Low Change	-0.0118 (-2.65%)
High	$0.4700
High Change	+0.0250 (+5.62%)
Range	$0.0368
Volume	467.594K
Dollar Volume	$215.28K

Premarket

-0.0160(-3.41%)

Open	$0.4698
Close	$0.4538
Low	$0.4538
Low Change	-0.0160 (-3.41%)
High	$0.4700
High Change	+0.0002 (+0.04%)
Range	$0.0162
Volume	23.246K
Dollar Volume	$10.55K

After Hours Yesterday

+0.0001(+0.02%)

Open	$0.4605
Close	$0.4606
Low	$0.4538
Low Change	-0.0067 (-1.45%)
High	$0.4606
High Change	+0.0001 (+0.02%)
Range	$0.0068
Volume	1.213K
Dollar Volume	$558.71

Regular Trading Hours Yesterday

+0.0029(+0.64%)

Open	$0.4550
Close	$0.4579
Low	$0.4450
Low Change	-0.0100 (-2.20%)
High	$0.4699
High Change	+0.0149 (+3.27%)
Range	$0.0249
Volume	616.552K
Dollar Volume	$282.32K

Premarket Yesterday

-0.0021(-0.46%)

Open	$0.4545
Close	$0.4524
Low	$0.4436
Low Change	-0.0109 (-2.40%)
High	$0.4900
High Change	+0.0355 (+7.81%)
Range	$0.0464
Volume	14.525K
Dollar Volume	$6.57K

GT Biopharma Moving Averages

5 Day Moving Average (SMA5)	$0.4599
10 Day Moving Average (SMA10)	$0.4569
20 Day Moving Average (SMA20)	$0.4703
50 Day Moving Average (SMA50)	$0.6229
100 Day Moving Average (SMA100)	$0.6560
200 Day Moving Average (SMA200)	$1.2673

GT Biopharma Statistics

Average Volume (30 Days)	1.2M
P/E Ratio (Current)	-.35
EPS (Current)	-$1.29
Dividend Yield	1.91%
Free Cash Flow	—
Cash Ratio	2.94
Current Ratio	3.45
Quick Ratio	3.45
Debt to Equity	0.00
Enterprise Value	$5.18M
EV to EBITDA	-0.42
EV to Sales	—
Price to Book	2.07
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	—
Return on Assets	-4.25%
Return on Equity	-5.95%

GT Biopharma Stock Splits

There have been 2 stock splits for GT Biopharma (GTBP). The last reverse stock split occured on February 5, 2024 and reduced the outstanding shares at a ratio of 30:1.

Date	Type	Ratio
February 5, 2024	Reverse	30:1
February 11, 2021	Reverse	17:1